Lobectomy with mediastinal lymph node dissection represents the standard treatment approach for patients with resectable non-small cell lung cancer (NSCLC). Defining the stage of a malignant disease is crucial for planning therapy, estimating prognosis and for studies comparison
Tracking occult pN2 disease after mediastinal dissection in early stage lung cancer.
BENATO, Cristiano;Pilotto S
;Infante M;Bria E
2017-01-01
Abstract
Lobectomy with mediastinal lymph node dissection represents the standard treatment approach for patients with resectable non-small cell lung cancer (NSCLC). Defining the stage of a malignant disease is crucial for planning therapy, estimating prognosis and for studies comparison
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
